Delphinus Expands Executive Team With New Vice President of Engineering

Delphinus Medical Technologies Inc. has expanded its executive team with the addition of a new vice president of engineering. Chris Sanders joins the company with more more than 20 years of extensive global innovation and manufacturing expertise in the medical ultrasound domain.

Prior to Delphinus, Sanders was director of Ultrasound Research and Development at Toshiba Medical Research Institute, USA, where he led the global research group that drove the advancement of matrix array transducer design. With his direction the team established collaborative partnerships with renowned research institutions and generated multiple publications and strategic medical patents.  During his 17-year career at Siemens Medical Solutions Corporation, he held numerous senior management positions. Recognized for attracting expert talent and leading international development teams to exceed corporate objectives, while senior director of Product Management, he steered the global launch and commercialization of several new product lines, leveraging multi-dimensional cross-platform synergies that streamlined the time-to-market process and increased margins.

“Chris is a superb addition to the Delphinus team,” said Mark J. Forchette, president/CEO of Delphinus. “He brings a great depth of expertise and knowledge realized by the accomplishments he achieved during his tenure with leading medical imaging corporations.  We look forward to his guidance and vision directing our research and development teams, as we advance our SoftVue technology to address the need for solutions in breast cancer screening.”

Sanders earned his bachelor’s degree in mathematics from the University of Colorado in Boulder, with an emphasis in computer science. He also holds a Management of Technology Certification from the Weatherhead School of Management at Case Western Reserve in Cleveland, Ohio.

Delphinus developed an automated whole breast ultrasound system that utilizes a ring transducer technology to transmit and receive ultrasound signals. SoftVue captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast, according to the company. With a short scan time of one to two minutes per breast, SoftVue presents a volumetric image map of the whole breast, providing a consistent and uniform exam without reliance on operator skill and technique.

Based in Plymouth Township, Mich., Delphinus Medical Technologies develop medical imaging solutions. Its SoftVue circular array transducer technology is indicated for use as a B-mode ultrasonic imaging system and is not intended to be used as a replacement for screening mammography. Delphinus is capitalized through principal investments by Arboretum Ventures of Ann Arbor, Mich., Beringea of Farmington Hills, Mich., and North Coast Technology Investors, also of Ann Arbor.